Related Experiment Video
Updated: Apr 6, 2026
A Preclinical Murine Model of Hepatic Metastases
Published on: September 27, 2014
Mouse Models of Pancreatic Ductal Adenocarcinoma
Mariano Ponz-Sarvise1, David A Tuveson2, Kenneth H Yu3
1Cancer Biology, Cold Spring Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, NY 11724, USA.
Abstract:
Only 10% to 15% of patients with pancreatic ductal adenocarcinoma (PDAC) are candidates for potentially curative surgery due to the location or spread of disease at the time of diagnosis. Despite rapid progress in the understanding of the molecular mechanisms underlying PDAC, translation to effective therapies has been modest at best. One of the key tools available for studying biology and developing more effective therapeutics is the laboratory mouse, mus musculus. This article explores new and innovative approaches to mouse modeling and how these approaches can be utilized to move the field forward.
Insights
Pancreatic ductal adenocarcinoma (PDAC) has limited surgical options. Innovative mouse models are crucial for advancing our understanding and developing effective pancreatic cancer therapies.
Area of Science:
- Oncology
- Translational Research
- Animal Models
Background:
- Pancreatic ductal adenocarcinoma (PDAC) presents a significant therapeutic challenge, with only 10-15% of patients eligible for curative surgery at diagnosis.
- Despite advances in understanding PDAC molecular mechanisms, effective treatments remain limited.
Purpose of the Study:
- To explore novel and innovative mouse modeling approaches for pancreatic ductal adenocarcinoma.
- To discuss the utility of these advanced models in accelerating the development of more effective PDAC therapies.
Main Methods:
- Review of current and emerging mouse models relevant to pancreatic ductal adenocarcinoma research.
- Analysis of how these models facilitate the study of PDAC biology and therapeutic testing.
Main Results:
- Innovative mouse models offer enhanced recapitulation of PDAC heterogeneity and tumor microenvironment.
- These models provide powerful platforms for preclinical drug screening and validation.
Conclusions:
- Advanced mouse models are essential for overcoming the translational gap in pancreatic ductal adenocarcinoma research.
- Future progress in PDAC treatment hinges on the strategic implementation of cutting-edge mouse modeling techniques.
Related Concept Videos
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:43Mouse Models of Cancer Study